Equity Long-Short, Semiconductors, Fabricated Knowledge

Douglas O'Laughlin

Equity Long-Short, Semiconductors

Fabricated Knowledge

Learn more about the world's most important manufactured product. Meaningful insight, timely analysis, and an occasional investment idea.

Thematic (Sector/Industry)

<ul><li>Markets always act erratically, but I thought I would highlight one aspect that disproportionately impacts semiconductors.</li><li>Factor investing is not new, but we are in a unique period where Momentum has quite a period of outperformance and short-term outperformance.</li><li>This matters because semiconductors are (as far as my memory holds) the most significant weight in Momentum I’ve ever witnessed. </li></ul>

Markets always act erratically, but I thought I would highlight one aspect that disproportionately impacts semiconductors.Factor investing is not new, but we are in a unique period where Momentum has quite a period of outperformance and short-term outperformance.This matters because semiconductors are (as far as my memory holds) the most significant weight in Momentum I’ve ever witnessed. 

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>The UnitedHealth Group’s first quarter of 2026 demonstrated a generally solid operational and financial performance, supported by ongoing strategic initiatives across its primary business segments.</li><li>Total revenues grew modestly by 2% year-over-year to $111.7 billion, with adjusted earnings per share of $7.23 surpassing internal expectations.</li><li>Membership stood at 49.1 million, a slight decline from 49.8 million at the end of 2025, reflecting anticipated contraction especially in the individual ACA market.</li></ul>

The UnitedHealth Group’s first quarter of 2026 demonstrated a generally solid operational and financial performance, supported by ongoing strategic initiatives across its primary business segments.Total revenues grew modestly by 2% year-over-year to $111.7 billion, with adjusted earnings per share of $7.23 surpassing internal expectations.Membership stood at 49.1 million, a slight decline from 49.8 million at the end of 2025, reflecting anticipated contraction especially in the individual ACA market.

UnitedHealth Group’s Membership Decline: Planned Reset Or Growth Red Flag?

Global Healthcare Analyst

Tina Banerjee

<ul>
<li>
<a href="https://www.smartkarma.com/entities/asahi-intecc-co-ltd" target="_blank" data-smartkarma-citation="entities:15915:1" rel="noopener">Asahi Intecc (7747 JP)</a> is poised for multi-year growth through strong market demand for its technically superior guidewires, market leadership positioning, new product launches, and direct marketing initiatives.</li>
<li>In FY24, Asahi Intecc aims to achieve revenue of ¥100B (+11% YoY), a significant milestone. The company targets revenue of ¥110B and an operating profit margin of 23–25% in FY26.</li>
<li>Asahi Intecc is expected to be a continued beneficiary of global procedure volume recovery. The company is likely to achieve its medium-term business plan ahead of schedule.</li>
</ul>



Asahi Intecc (7747 JP) is poised for multi-year growth through strong market demand for its technically superior guidewires, market leadership positioning, new product launches, and direct marketing initiatives.
In FY24, Asahi Intecc aims to achieve revenue of ¥100B (+11% YoY), a significant milestone. The company targets revenue of ¥110B and an operating profit margin of 23–25% in FY26.
Asahi Intecc is expected to be a continued beneficiary of global procedure volume recovery. The company is likely to achieve its medium-term business plan ahead of schedule.


2024 High Conviction: Asahi Intecc (7747 JP)- Procedure Volume Recovery to Accelerate Growth

<ul><li>UnitedHealth Group’s full year 2025 financial results demonstrated resilience amid a period of strategic realignment and operational challenges.</li><li>The company reported adjusted earnings per share of $16.35, slightly exceeding expectations despite incurring a net-of-tax, largely noncash charge of $1.6 billion tied principally to restructuring and portfolio optimization activities within its Optum segment.</li><li>Revenue grew 12% year-over-year to nearly $448 billion, supported by over 415,000 net domestic membership additions.</li></ul>

UnitedHealth Group’s full year 2025 financial results demonstrated resilience amid a period of strategic realignment and operational challenges.The company reported adjusted earnings per share of $16.35, slightly exceeding expectations despite incurring a net-of-tax, largely noncash charge of $1.6 billion tied principally to restructuring and portfolio optimization activities within its Optum segment.Revenue grew 12% year-over-year to nearly $448 billion, supported by over 415,000 net domestic membership additions.

UnitedHealth Group Is Losing Members in Key Segments—So Where Will Growth Actually Come From?

<ul><li>UnitedHealth Group's third quarter performance of 2025 reflects both the opportunities and challenges within its enterprise.</li><li>The company's leadership team recognizes the diverse pace of progress across its divisions, such as UnitedHealthcare and the Optum Health and Optum Insight segments.</li><li>UnitedHealth Group is focusing on margin improvement and operational enhancements, intending to fully realign with their long-term goals, despite current headwinds and sector-specific challenges such as heightened medical cost trends and funding pressures.</li></ul>

UnitedHealth Group's third quarter performance of 2025 reflects both the opportunities and challenges within its enterprise.The company's leadership team recognizes the diverse pace of progress across its divisions, such as UnitedHealthcare and the Optum Health and Optum Insight segments.UnitedHealth Group is focusing on margin improvement and operational enhancements, intending to fully realign with their long-term goals, despite current headwinds and sector-specific challenges such as heightened medical cost trends and funding pressures.

UnitedHealth Group Is Repositioning Medicare Advantage Amid Funding Cuts—Are These Strategic Exits A Smart Defensive Play?

United States

UnitedHealth Group Incorporated owns and manages organized health systems. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

UnitedHealth Group (UNH UN)

Factors and Semiconductors

A friendly warning. Momentum is outperforming all factors this year, and Semiconductors are a large part of that. Markets always act erratically,...

Fabricated Knowledge

UnitedHealth Group’s Membership Decline: Planned Reset Or Growth Red Flag?

The UnitedHealth Group’s first quarter of 2026 demonstrated a generally solid operational and financial performance, supported by ongoing...

Baptista Research

2024 High Conviction: Asahi Intecc (7747 JP)- Procedure Volume Recovery to Accelerate Growth

Asahi Intecc is poised for double-digit sales growth through FY26, driven by strong market demand for guidewires, market leadership positioning,...

Tina Banerjee

UnitedHealth Group Is Losing Members in Key Segments—So Where Will Growth Actually Come From?

UnitedHealth Group’s full year 2025 financial results demonstrated resilience amid a period of strategic realignment and operational...

Baptista Research

UnitedHealth Group Is Repositioning Medicare Advantage Amid Funding Cuts—Are These Strategic Exits A Smart Defensive Play?

UnitedHealth Group's third quarter performance of 2025 reflects both the opportunities and challenges within its enterprise. The company's...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)